DGEYX
Price
$31.01
Change
+$0.07 (+0.23%)
Updated
Sep 11 closing price
Net Assets
294.66M
RNWHX
Price
$107.05
Change
-$0.71 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
Interact to see
Advertisement

DGEYX vs RNWHX

DGEYX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
DGEYX vs. RNWHX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGEYX is a Buy and RNWHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90B vs. DGEYX (295M). RNWHX pays higher dividends than DGEYX: RNWHX (1.15) vs DGEYX (0.32). DGEYX was incepted earlier than RNWHX: DGEYX (13 years) vs RNWHX (11 years). DGEYX (0.91) is less costly to investors than RNWHX (0.72). DGEYX is a more actively managed with annual turnover of: 71.79 vs. RNWHX (46.00). RNWHX has a lower initial minimum investment than DGEYX: RNWHX (250) vs DGEYX (1000000). DGEYX annual gain was more profitable for investors over the last year : 25.16 vs. RNWHX (17.19). RNWHX return over 5 years is better than : 17.68 vs. DGEYX (10.35).
DGEYXRNWHXDGEYX / RNWHX
Total Expense Ratio0.910.72126%
Annual Report Gross Expense Ratio0.910.72126%
Fund Existence13 years11 years-
Gain YTD20.52116.447125%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets295M90B0%
Annual Yield % from dividends0.321.1528%
Returns for 1 year25.1617.19146%
Returns for 3 years58.7853.84109%
Returns for 5 years10.3517.6859%
Returns for 10 years126.10111.44113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPEX46.310.28
+0.61%
Fidelity Advisor Low-Priced Stock C
FACDX64.25N/A
N/A
Fidelity Advisor Health Care A
EXHAX26.61N/A
N/A
Manning & Napier Pro-Blend Max Term S
LMCFX35.98N/A
N/A
Lord Abbett Mid Cap Stock F
MSAWX22.51N/A
N/A
Morgan Stanley Inst Asia Opp C